louisiana glp-1 constipation class action Ozempic Lawsuit Ozempic Lawsuit [July 2026 Update]

Unknown Risks: Given its influence on fundamental metabolic processes (AMPK) and mTOR regulation, the long-term safety of chronic, supraphysiological MOTS-c administration is unknown and requires caution

Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic

Journal of Neurochemistry, 151(2), 135-149

Large clinical trials including STEP and SELECT demonstrate that participants who continued GLP-1 medications maintained their weight loss, while those who switched to placebo regained an average of two-thirds of lost weight

Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership BMJ Open 2022;12:e065166